Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:35:23 2024-07-12 am EDT			5-day change	1st Jan Change
26.94 ^EUR	+1.11%		+2.94%	-19.91%

Jul. 12	European Midday Briefing : Stocks Extend Rally as U.S. Rate Cut Hopes Deepen	DJ
Jul. 12	BAYER AG : Jefferies gives a Neutral rating	ZD

BAYER AG : NorldLB remains its Buy rating

January 06, 2021 at 08:55 am EST

Thorsten Strauß from NorldLB retains his positive opinion on the stock with a Buy rating.

Latest news about Bayer AG

European Midday Briefing : Stocks Extend Rally as U.S. Rate Cut Hopes Deepen	Jul. 12	DJ
BAYER AG : Jefferies gives a Neutral rating	Jul. 12	ZD
Cooling Inflation in Germany, US Boosts DAX Index	Jul. 11	MT
Bayer: FDA Fast Track designation for Parkinson's treatment	Jul. 11	CF
Bayer's Gene Therapy for Parkinson's Gets US Fast Track, UK Innovation Passport Designations	Jul. 11	MT
Fast-track status for gene therapy boosts Bayer	Jul. 11	DP
BASF announces planned closure of two weed killer sites in Germany	Jul. 10	RE
BAYER AG : JP Morgan reaffirms its Neutral rating	Jul. 10	ZD
European companies cut jobs as economy sputters	Jul. 09	RE
BAYER AG : Gets a Neutral rating from Deutsche Bank	Jul. 09	ZD
That's not so bad, is it?	Jul. 08
Silver lining but no stable upturn - VCI maintains its forecast	Jul. 08	RE
BAYER AG : Goldman Sachs reiterates its Neutral rating	Jul. 08	ZD
Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	Jul. 02	CI
Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	Jun. 28	DP
Chemicals collective agreement: Bonus days for union members	Jun. 27	DP
German chemical sector employers, union agree 6.85% pay hike over 20 months	Jun. 27	RE
Chemicals collective bargaining agreement: extra day for trade unionists	Jun. 27	DP
The same old winners	Jun. 27
Bayer's pharmaceuticals division plans to cut further managerial jobs	Jun. 27	RE
Bayer's Pharmaceuticals Unit to Cut More Managerial Jobs Amid Reorganization	Jun. 27	MT
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia	Jun. 26	RE
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...	Jun. 26
Dpa-AFX Overview: COMPANIES from 26.06.2024 - 15:15	Jun. 26	DP
Anton switch to Dortmund perfect? Voller rows back	Jun. 26	DP

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

2024-08-06 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.94 EUR

Average target price

36.14 EUR

Spread / Average Target

+34.16%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-19.91%	28.86B
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

BAYER AG : NorldLB remains its Buy rating

Latest news about Bayer AG

Chart Bayer AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Bayer AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals